These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 29575433)
1. Gold(III) Complexes for Antitumor Applications: An Overview. Bertrand B; Williams MRM; Bochmann M Chemistry; 2018 Aug; 24(46):11840-11851. PubMed ID: 29575433 [TBL] [Abstract][Full Text] [Related]
2. Chemical biology of anticancer gold(III) and gold(I) complexes. Zou T; Lum CT; Lok CN; Zhang JJ; Che CM Chem Soc Rev; 2015 Dec; 44(24):8786-801. PubMed ID: 25868756 [TBL] [Abstract][Full Text] [Related]
3. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure. Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647 [TBL] [Abstract][Full Text] [Related]
4. Cyclometalated Gold(III) Complexes Containing N-Heterocyclic Carbene Ligands Engage Multiple Anti-Cancer Molecular Targets. Fung SK; Zou T; Cao B; Lee PY; Fung YM; Hu D; Lok CN; Che CM Angew Chem Int Ed Engl; 2017 Mar; 56(14):3892-3896. PubMed ID: 28247451 [TBL] [Abstract][Full Text] [Related]
5. A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds. Bertrand B; Casini A Dalton Trans; 2014 Mar; 43(11):4209-19. PubMed ID: 24225667 [TBL] [Abstract][Full Text] [Related]
6. A Gold(III) Pincer Ligand Scaffold for the Synthesis of Binuclear and Bioconjugated Complexes: Synthesis and Anticancer Potential. Bertrand B; O'Connell MA; Waller ZAE; Bochmann M Chemistry; 2018 Mar; 24(14):3613-3622. PubMed ID: 29334159 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole. Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability. Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands. Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197 [TBL] [Abstract][Full Text] [Related]
11. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties. Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L J Inorg Biochem; 2012 Mar; 108():123-7. PubMed ID: 22173093 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of polymeric gold glyco-conjugates as anti-cancer agents. Ahmed M; Mamba S; Yang XH; Darkwa J; Kumar P; Narain R Bioconjug Chem; 2013 Jun; 24(6):979-86. PubMed ID: 23631753 [TBL] [Abstract][Full Text] [Related]
13. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes. Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538 [TBL] [Abstract][Full Text] [Related]
14. Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents. Wang X; Guo Z Dalton Trans; 2008 Mar; (12):1521-32. PubMed ID: 18335133 [TBL] [Abstract][Full Text] [Related]
15. Organogold(III)-dithiocarbamate compounds and their coordination analogues as anti-tumor and anti-leishmanial metallodrugs. de Andrade Querino AL; de Sousa AM; Thomas SR; de Lima GM; Dittz D; Casini A; do Monte-Neto RL; Silva H J Inorg Biochem; 2023 Oct; 247():112346. PubMed ID: 37536162 [TBL] [Abstract][Full Text] [Related]
16. Acridine-decorated cyclometallated gold(iii) complexes: synthesis and anti-tumour investigations. Williams MRM; Bertrand B; Fernandez-Cestau J; Waller ZAE; O'Connell MA; Searcey M; Bochmann M Dalton Trans; 2018 Oct; 47(38):13523-13534. PubMed ID: 30204186 [TBL] [Abstract][Full Text] [Related]
17. Insights into the reactivity of gold-dithiocarbamato anticancer agents toward model biomolecules by using multinuclear NMR spectroscopy. Boscutti G; Marchiò L; Ronconi L; Fregona D Chemistry; 2013 Sep; 19(40):13428-36. PubMed ID: 24038383 [TBL] [Abstract][Full Text] [Related]
18. Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents. Chaves JDS; Tunes LG; de J Franco CH; Francisco TM; Corrêa CC; Murta SMF; Monte-Neto RL; Silva H; Fontes APS; de Almeida MV Eur J Med Chem; 2017 Feb; 127():727-739. PubMed ID: 27823888 [TBL] [Abstract][Full Text] [Related]
19. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties. Li CK; Sun RW; Kui SC; Zhu N; Che CM Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives. Wang S; Shao W; Li H; Liu C; Wang K; Zhang J Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]